Pharmaceutical Preparations · CIK 1664710
Developing novel therapeutics for disorders linked to dysfunctional TGF-ß signaling pathways
Comparable business profile · signals at a glance
In the 90 days to Mar 9, 2026: 1 insider bought $22K · 4 sold $332K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 | Bienaime Jean JacquesDirector | Buy | 2,000 | $11.21 | $22K |
| Feb 19, 2026 | Seehra JasbirCHIEF EXECUTIVE OFFICER | Sell | 7,015 | $16.17 | $113K |
| Feb 18, 2026 | Cho EstherSVP, General Counsel | Sell | 4,745 | $16.35 | $78K |
| Feb 18, 2026 | Regnante KeithCHIEF FINANCIAL OFFICER | Sell | 4,739 | $16.35 | $77K |
| Feb 18, 2026 | Lerner Lorena RaquelChief Science Officer | Sell | 3,873 | $16.35 | $63K |
| Oct 15, 2025 | Schneeberger DanielTenPercentOwner | Sell | 4,391,237 | $17.75 | $77.9M |
| Oct 15, 2025 | Pontifax (China) Iv L.P.TenPercentOwner | Sell | 2,284,612 | $17.75 | $40.6M |
| Oct 15, 2025 | Pontifax (China) Iv L.P.TenPercentOwner | Sell | 1,226,412 | $17.75 | $21.8M |
| Oct 15, 2025 | Pontifax (China) Iv L.P.TenPercentOwner | Sell | 1,121,045 | $17.75 | $19.9M |
| Oct 15, 2025 | Schneeberger DanielTenPercentOwner | Sell | 743,358 | $17.75 | $13.2M |
| Oct 15, 2025 | Schneeberger DanielTenPercentOwner | Sell | 254,669 | $17.75 | $4.5M |
| Oct 15, 2025 | Pontifax (China) Iv L.P.TenPercentOwner | Sell | 155,262 | $17.75 | $2.8M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.